SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " abe " 100 found 🔀 AI-powered Shuffle
Sign in to save shuffle history.
Four receptions for Chris Godwin Jr.
Buccaneers WR Chris Godwin Jr. leads team with four receptions in Week 7 win
MCHD: Several people treated at local emergency rooms for bat bites in Baldwin County
The Mobile County Health Department says the patients were bitten at different residences in Baldwin County.
Sullivan, Peltola seek support from Alaska Native voters ahead of crucial Senate race
The major candidates in Alaska’s U.S. Senate race are both casting themselves as strong voices on Alaska Native issues as they seek support from the key constituency ahead of the Nov. 3 election.
Ravens surrender 35 unanswered points in stunning loss to Bengals
Baltimore squandered a 13-0 halftime lead as Joe Burrow threw four touchdown passes and Cincinnati handed the Ravens a 35-13 defeat
These Milwaukee Brewers are two games from immortality in World Series
The Wake Forest Refocus
Wake Forest is done resting for the season, and it is time to refocus. After a bye week, the Demon Deacons are 6-1 overall and 4-1 in the conference with five games left in the season. They are home Saturday against the Virginia Cavaliers, who come into Winston-Salem 4-4 overall and 2-3 in conference play. …
Syracuse Football: First November Kickoff Now Scheduled
The Orange will host the Clemson Tigers at the JMA Wireless Dome, looking to beat their rivals for the second straight year.
Georgia lands son of music star in notable recruitment win
Georgia football secured a notable win during its bye week Sunday. And in the process, coach Kirby Smart and company win over fans of country star Luke Bryan. That’s because his son Bo Bryan is joining the 2027 recruiting class. The three-star quarterback chose the Bulldogs officially, becoming the newest College Football Recruiting win for […] The post Georgia lands son of music star in notable recruitment win appeared first on ClutchPoints.
New Jersey Cannot Prescribe Better Health Without Making Healthy Food Accessible
By Assemblyman Kenyatta Stewart We tell people with diabetes to watch their blood sugar. We tell people with hypertension to reduce their sodium. We tell families to eat more fruits and vegetables to prevent chronic disease. But what happens when the food we recommend is beyond their budget or unavailable in their neighborhood? That is[...]
Elizabeth Holmes film puts up a fight against 'Clayface' at box office
A movie set in the world of Batman and a three-hour documentary about Elizabeth Holmes went head-to-head at the box office this weekend, and it turned out to be a closer contest than expected.
Human Evolution and Disease: How Ancient DNA Shapes Modern Health Risks
Ancient DNA and evolutionary medicine help explain how inherited genetic variants interact with changing environments to influence modern disease risk. Neanderthal ancestry, metabolic variation, and evolutionary trade-offs provide insights into immunity, obesity, type 2 diabetes, and aging.
Exclusive: Numeracle Raises $28M To Keep Legitimate Business Calls From Spam Label
Numeracle, a McLean, Virginia-based company that verifies businesses and links their identities to the phone numbers they use to contact customers, has raised $28 million from Edison Partners to help businesses whose calls are incorrectly labeled as spam or blocked by phone carriers.
She voted for Trump every time. Then came cancer and the bills
Cindy Banda faces mounting medical bills after battling breast cancer.
Blanche says Trump isn't trying to meddle with Alaska election results by suing over Senate race
Attorney General Todd Blanche is defending the Trump administration’s lawsuit to block certification of Alaska's Senate results if incumbent Republican Dan Sullivan loses the race.
Ian-credible Science: DNA extraction with Dr. Elizabeth Racz-Brunner
Each week, we bring you a quick and easy experiment you can do at home to explore a concept in science. This week, we’re on the road at South Dakota Mines to learn about DNA extraction.
Alan Dysert, “All My Children” star, dies at 75 after being diagnosed with ‘incurable cancer’
The actor discussed his condition in his 2023 book “Lights, Camera, Cancer.”
Vera Health secures $28.5M series A for AI-driven clinical search engine
Clinical artificial intelligence search engine Vera Health secured $28.5 million in series A funding to accelerate and expand its platform. | Vera Health’s platform scans more than 60 million peer-reviewed publications, clinical guidelines, consensus statements and drug labels, executives say.
Freddy Peralta was beloved in Milwaukee. Now he stands in Brewers’ World Series path
Elizabeth Holmes film puts up a fight against 'Clayface' at box office
A movie set in the world of Batman and a three-hour documentary about Elizabeth Holmes went head-to-head at the box office this weekend, and it turned out to be a closer contest than expected.
Patrick Mahomes Earns New Nickname From Kansas City Chiefs
Conte breaks silence amidst reports he could return to Juventus
Several reports have linked Antonio Conte with a return to Juventus and a possible move to Manchester United, with both clubs reportedly considering changes in the dugout. Conte continues to be associ...
ESMO: Roche touts ‘convincing’ phase 3 KRAS data after win over rivals
Roche has shed more light on its investigational KRAS G12C inhibitor's phase 3 victory over Amgen’s Lumakras and Bristol Myers Squibb’s Krazati. The open-label Krascendo 1 trial enrolled 338 people with previously treated KRAS G12C-mutated non-small cell lung cancer (NSCLC). Patients who had already received a KRAS G12C inhibitor or pan-KRAS/RAS inhibitor were excluded from the trial. Participants received either divarasib once daily, Lumakras once daily or Krazati twice daily. Roche announced back in July that divarasib had demonstrated statistically significant improvements in progression-free survival (PFS) and overall survival (OS), meeting the trial’s primary and key secondary endpoints. But the Swiss pharma had been holding back the detailed data until now. At the European Society for Medical Oncology (ESMO) Congress in Madrid, Roche revealed that median OS for the 167 patients who received divarasib was 17.7 months, compared to 12 months for the 171 patients who received Lumakras or Krazati. The benefit was similarly clear when it came to median PFS, which stood at 9.8 months versus 5.7 months, respectively. A total of 44% of patients receiving divarasib were alive without disease progression at one year, compared to 24% of the control group, according to Roche’s presentation. It was a similar story for the objective response rate, which came in at 58% for divarasib versus 32% for the control group, while median duration of response was 11.9 months versus 6.9 months. Stefan Frings, M.D., Ph.D., deputy chief medical officer at Roche Pharma, told Fierce that the data made for a “very comprehensive, strong package, which should be convincing to health authorities.” “It’s an important advance for patients with lung cancer,” Frings said in an interview at a Madrid hotel during the conference. “It's a second-line setting, and patients who receive divarasib benefit compared to the current first-generation KRAS G12C inhibitors by having far longer overall survival,” he continued. “They live longer. They have better progression-free survival, better response rates, and with a safety profile which is—if [anything]—even better,” he said. According to Roche, 4.8% of patients receiving divarasib discontinued treatment due to treatment-related adverse events, compared to 11.7% in the control group. Serious treatment-related adverse events were also less common with divarasib, at 7.8% versus 15.2%. Roche’s confidence in divarasib had been building even before this phase 3 success. The candidate had already shown better potency and selectivity than the incumbent KRAS G12C inhibitors Krazati and Lumakras in preclinical tests. After cross-trial comparisons suggested that the edge translated into better clinical outcomes, Roche axed a study comparing divarasib to the chemotherapy docetaxel and went toe-to-toe with Lumakras and Krazati. “We designed the drug on purpose with higher potency and better selectivity,” Frings explained. “So, based on preclinical models, we clearly knew it would be superior to the first generation.” “It’s honestly not so frequent that pharma companies go head-to-head,” he added. “But if you want to make a point, if you want to convince payers, prescribers and patients … then a head-to-head win is rather rewarding.” While Amgen and BMS reached the regulatory finish line first for KRAS G12C-mutated, locally advanced or metastatic NSCLC in 2021 and 2022, respectively, they have struggled to capitalize on their head start. Krazati brought in $55 million for BMS in the second quarter, while Lumakras delivered $111 million to Amgen. For its part, Roche is aiming for peak divarasib sales of 1 billion to 2 billion Swiss francs ($1.2 billion to $2.5 billion), according to Frings. The Big Pharma is currently recruiting patients into a phase 3 trial comparing divarasib plus Keytruda against Keytruda plus chemotherapy in previously untreated advanced or metastatic nonsquamous KRAS G12C-mutated NSCLC. Roche has previously suggested that sales in metastatic disease would account for most of the forecast. Frings was tight-lipped on the exact timeline for a regulatory filing but said the Swiss pharma is “certainly keen to get this to as many patients as possible around the world.” Roche has more RAS drugs coming up behind divarasib. The pharma has already launched phase 1 trials of a pan-RAS inhibitor called RG6505 and a KRAS G12D inhibitor dubbed RG6620 in solid tumors. Roche’s partner Chugai Pharmaceutical is also testing a pan-KRAS inhibitor called AUBE00. Roche has made a “deliberate effort” to test a range of RAS drugs, Frings said. “If you have many rare mutations and you are scrambling to find sufficient patients, a pan-RAS inhibitor makes a lot of sense,” he explained.
Better than Brian Lara? Dinesh Karthik decodes the science behind Vaibhav Sooryavanshi’s massive backlift punch and brute power
Dinesh Karthik broke down the biomechanics behind Vaibhav Sooryavanshi's power-hitting.
The Latest: Trump pushing to keep red-state Senate seats in GOP hands
President Donald Trump told Texans they’d better accept data centers in their communities and floated making Venezuela the 51st state as he stumped for Republican Ken Paxton, while Democratic Senate candidate James Talarico said a “corruption crisis” plagues U.S. politics.
Did Elizabeth Holmes and Billy Evans get paid for their documentary?
Nathan Fielder’s documentary turns a dispute over paying its subjects into a central source of tension. Here’s what we know about the proposed deal.
Mike Vrabel is not concerned about A.J. Brown: ‘Just have to get back into a rhythm’
| WEEI 93.7
Clayface Takes First Place While Holmes Documentary Grows in Week Two
Clayface opened with $24.5M, while A24's three-hour Elizabeth Holmes documentary You Can See Everything grew 25% in its second weekend.
Cancer and family finances make health care debate personal for Nunn, Trone Garriott
Their mothers’ cancer experiences made health care personal in the Nunn–Trone Garriott debate. Here’s what they said about the Affordable Care Act and affordability.
Inside Business 2026 Top Forty Under 40: Carley McClintock, Elizabeth River Crossings
Carley McClintock works in communications and community relations at Elizabeth River Crossings.
Brewers' Chourio Ties Ruth's 98-Year-Old World Series Record
The 22-year-old phenom matched Babe Ruth's historic 1928 mark, igniting the Milwaukee Brewers' offense in the World Series.
6 citizens sue Trump, saying media ban deprives them of news as audience stakeholders
A new lawsuit against President Donald Trump's media ban stakes a claim for the public itself.
Health care discrimination may silence diabetes conversations among Black men
Managing type 2 diabetes requires more than occasional visits to the doctor's office. Much of the work happens between appointments, making communication and support from others an important part of managing ...
Chiefs News: Harrison Butker may have competition amid struggles
The latest Chiefs news, brought fresh to you every morning!
Shia LaBeouf waged one-sided feud with Hilary Duff, says ‘Even Stevens’ costar
Christy Carlson Romano says her ‘Even Stevens’ costar, Shia LaBeouf, was ‘beefing’ with Hilary Duff during their overlapping Disney Channel days: ‘He had to be the number one.’
Olympiacos vs. Rennes Could Be Moved Due to French Strike
Olympiacos' Europa League match against Rennes could be moved to Nov. 4 due to a general strike and protests in France. Here's what we know.
Scientists Discover a Plant Compound That Could Help Stop Rheumatoid Arthritis Inflammation
Scientists have identified a plant compound that reduced joint swelling and inflammation in rats with experimental arthritis. The discovery offers a potential new direction for rheumatoid arthritis tr...
Amo Celebrates $1.2 Million Federal Investment in Cumberland Stormwater Improvements to Protect Local Businesses and Jobs
Cumberland, RI – TODAY, Congressman Gabe Amo (D-RI-01) joined local leaders today to celebrate the completion of a $1.2 million stormwater infrastructure project along Industrial Road, helping Cumberland address chronic flooding in its largest commercial area and better protect the businesses, workers, and infrastructure that keep its economy moving.
Groundskeepers at prepare the bullpen mounds at Tropicana Field
Groundskeepers prepare the bullpen mounds at Tropicana Field in preparation for the World Series in St. Petersburg, Florida.
Elizabeth Debicki’s reaction to seeing Alexander Skarsgård in full-frontal “Wicker” costume was to turn ‘bright red’
The actress encountered her leading man as he was in the water.
Has Taylor Moton played final NFL game with Panthers?
Carolina's veteran right guard fractured his fibula on Sunday, leaving his NFL future in doubt.
Epic CEO Tim Sweeney lambasts “abhorrent” Steam AI Disclosure Policy claiming labels double as “political statement”
Epic Games CEO Tim Sweeney called Steam’s AI disclosure policy abhorrent, arguing that it exposes developers to backlash from anti-AI detractors. Valve has implemented and updated the policy since 2024, which states that AI-generated content, including artwork, text, music, and assets, excluding assistant tools, requires formal disclosure.
Yankees' David Bednar Gets $55 Million Contract Prediction
The New York Yankees have some key players hitting the open market this offseason
Kyle Larson’s Championship Moment Comes at Talladega
Conquering his drafting-track demons, Larson surged from mid-pack chaos to secure a historic Hendrick 1-2 finish, building a massive points cushion that places the title within reach
Billy Evans' 'You Can See Everything' shower scene was his idea
Billy Evans — the partner of Theranos founder Elizabeth Holmes — asked the 'You Can See Everything' team: 'Want to film me showering?'
More voters are leaving party labels behind, as national politics reshape in WV
A growing number of West Virginia residents choosing to register without a political party, a shift that comes as the state’s political identity continues to change. Interviews with voters and political observers suggest that, for some, leaving a party is less about abandoning politics and more about feeling that neither major party fully represents their beliefs.
3 Way-Too-Early Pittsburgh Pirates Offseason Predictions
Will the Pittsburgh Pirates continue to be aggressive this offseason?
My divorce made headlines. Now I help survivors of toxic relationships tell their stories.
Elizabeth Chambers on rebuilding after her high-profile divorce from Armie Hammer, raising her kids and what survivors have taught her through her ID series "Toxic."
Fed, Alphabet, Microsoft, Amazon set up 48-hour stock market test for AI
The Fed will set the rate backdrop, while Alphabet, Microsoft, and Amazon face fresh questions about AI spending.
How to Manage Symptoms of Heart Failure
(Feature Impact) Americans are facing a growing health challenge, with 1 in 4 adults at risk of heart failure, according to the Heart Failure Society of America. Additionally, approximately 6.7 million U.S. adults who are 20 years old or older are currently living with heart failure, and that number is projected to reach 8.7 million by 2030. googletag.cmd.push(function() { googletag.display('JGFI_Article_300x250'); }); Managing heart failure is a significant expense to the U.S. healthcare system, costing the nation approximately $40 billion in 2020 and expected to increase to approximately $142 billion a year by 2050.If you (or a loved one) are living with the condition, consider these tips to help manage it.Adhere to the Treatment and Follow-Up PlanOngoing outpatient care is important when managing heart failure. Understand the treatment plan provided by your healthcare team, make diet and lifestyle changes, take medications as directed and keep recommended follow-up appointments.Pay attention to changes in symptoms and communicate with your healthcare provider if treatment does not seem to be working as expected. If their conditions are left unmanaged, patients can experience a range of heart-failure-related symptoms such as shortness of breath, fatigue, buildup of fluid and more.Understand Challenges with Diuretic TreatmentDiuretics help the body remove excess fluid and are commonly used to treat swelling, or edema, associated with heart failure. Your provider may try different diuretics, sometimes referred to as “water pills,” to manage your heart failure symptoms. However, intravenous (IV) diuretic therapy may be required for some patients if symptoms continue.Ask About Treatment Options Before IV Care Is NeededFor some adults, a healthcare provider may consider recommending an at-home, non-oral diuretic option prior to escalating to IV therapy.For example, ENBUMYST™ (bumetanide nasal spray) is a prescription diuretic used in adults to treat edema associated with congestive heart failure. It’s administered as a nasal spray for short-term use to manage excess fluid with the goal of transitioning to oral diuretic therapy when appropriate.Talk with your healthcare provider to learn more and visit enbumyst.com. Read the full Prescribing Information and Patient Information.Photo courtesy of Shutterstock googletag.cmd.push(function() { googletag.display('JGFI_Article2_300x250'); }); Important Safety InformationWhat is ENBUMYST?ENBUMYST is a prescription medicine used in adults to treat swelling caused by excess fluid in the body (edema) from congestive heart failure, liver disease, and kidney disease.What is the most important information I should know about ENBUMYST?ENBUMYST is a diuretic that helps your body remove fluid. Losing too much fluid can cause dehydration, low blood volume, and increase the risk of blood clots. Blood abnormalities may include decreased salts (electrolytes), and increased nitrogen, glucose and uric acid. The risk of these abnormalities is higher in elderly people, those using higher doses, or those who do not get enough electrolytes by mouth.You should not use ENBUMYST if you have severe electrolyte loss. Tell your healthcare provider if you experience unusual thirst; dizziness or lightheadedness; weakness or tiredness; fast heart rate; dry mouth or tongue; sudden pain; redness or swelling in your joints; pain, swelling, redness, or warmth in your leg; shortness of breath or fast breathing; high blood sugar; dark urine; pale, tight, cool or clammy skin; muscle cramps; confusion.Do not use ENBUMYST if you have low or no urine production or are allergic to bumetanide or to any of the ingredients in ENBUMYST.Before using ENBUMYST, tell your healthcare provider if you have low electrolytes, are on a low-salt diet, have diarrhea, diabetes, nasal problems such as a runny or stuffy nose or polyps, a history of nasal injury or surgery, are or plan to become pregnant, are or plan to breastfeed.Tell your healthcare provider about all the medicines you take, including prescriptions, over-the-counter medicines, vitamins, and herbal supplements.ENBUMYST may cause serious side effects, such as worsening kidney function and ringing in the ears or hearing loss.The most common side effects of ENBUMYST include dehydration, headache, muscle cramps, dizziness, low blood pressure, nausea, and abnormal brain functioning with certain liver problems.These are not all the possible side effects of ENBUMYST. Talk to your healthcare provider for more information.Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.US-ENBU-2600110 googletag.cmd.push(function() { googletag.display('JGFI_Article3_300x250'); });
Unwanted endorsement: Political ad causes uproar at Jerusalem's Lev Academic Center
Those who know the highly regarded college, which since 1969 has produced religious graduates with degrees in a variety of engineering fields and nursing, were likely surprised. Thousands of drivers a...
Giants should send Malik Nabers at Houston’s weakened middle
Houston will be without safeties Reed Blankenship and Jalen Pitre on Sunday. I’d make those absences part of the Giants‘ […]
Scientists Discover How Excess RNA Can Disrupt the Energy Supply Inside Cells
Scientists at Texas A&M University discovered that excess RNA can interfere with the machinery cells use to produce energy, even without triggering certain immune defenses. The findings reveal an unex...
3 Cubs Who Will Decline Their Options
Iowa Football Was Never Truly A CFP-Caliber Team. The Loss To Minnesota Proved It
The Hawkeyes had plenty of momentum after the Washington game, but there's just too much inconsistency right now. Everything fell apart against Minnesota.
How Trump’s ‘little detour’ to Iran became a roadblock in the midterm elections
When President Donald Trump launched his war on Iran, he said it would last a matter of weeks.
Cincinnati Reds Made Massive Mistake With Ke’Bryan Hayes
The Cincinnati Reds made a massive mistake acquiring infielder Ke'Bryan Hayes.
2026's First $1 Billion Movie Finally Confirms Netflix Release Date
Ravens QB Lamar Jackson Downgraded to OUT for Bengals Game
Baltimore Ravens quarterback Lamar Jackson has been downgraded to OUT for the Bengals game.
Milk Protein Peptide Eases Blood Sugar Problems In Diabetic Mice
A dairy protein fragment calmed blood sugar swings and inflammation in diabetic mice, pointing to a possible food-based tool for blood sugar support.
Brackets: Section 1 football postseason results, schedule, scores
Action begins this week.
Investment driving growth at NWS Crane
.video-js, .video-js .vjs-tech { position: relative; width: 100%; height: auto; z-index: 0; } var player = videojs('player_block_53b5ab82222c602125d1d037b3aaa781'); player.nuevo({ contextMenu: false }); var vast = { started: false, paused: false, resumed: false, ended: false, }; var video = { started: false, paused: false, resumed: false, ended: false, } var event_label = 'Video: 210156 - Article: Investment driving growth at NWS Crane'; var post_id = 210174; var post_url = "https://www.insideindianabusiness.com/videos/investment-driving-growth-at-nws-crane"; player.vastAds({ tagURL: "https://servedbyadbutler.com/vast.spark?setID=13487&ID=177008&pid=117129", id: "PreRoll" }); player.on('vast.adStart', function() { vast.started = true; }); player.on('vast.adError', function() { vast = { started: true, ended: true }; }); player.on('play', function() { if (vast.ended && !video.paused) { video.started = true; window.dataLayer.push({ event: "Videos", eventCategory: 'Video', eventAction: "Video Played", eventLabel: event_label }); var audio_insight_data = { event_type: "video_played", data: { video_id: post_id, video_url: post_url }, ...insight_data, }; insight.track(audio_insight_data); } if (video.started && video.paused) { video.resumed = true; window.dataLayer.push({ event: "Videos", eventCategory: 'Video', eventAction: "Video Resumed", eventLabel: event_label }); var audio_insight_data = { event_type: "video_resumed", data: { video_id: post_id, video_url: post_url }, ...insight_data, }; insight.track(audio_insight_data); } }); player.on('pause', function() { if (vast.ended) { video.paused = true; window.dataLayer.push({ event: "Videos", eventCategory: 'Video', eventAction: "Video Paused", eventLabel: event_label }); var audio_insight_data = { event_type: "video_paused", data: { video_id: post_id, video_url: post_url }, ...insight_data, }; insight.track(audio_insight_data); } }); player.on('ended', function() { //vast.adEnd fires after ended, pointless to use. vast.ended = true; if (video.started && !video.ended) { video.ended = true; window.dataLayer.push({ event: "Videos", eventCategory: 'Video', eventAction: "Video Ended", eventLabel: event_label }); } var audio_insight_data = { event_type: "video_completed", data: { video_id: post_id, video_url: post_url, percentage: 100, }, ...insight_data, }; insight.track(audio_insight_data); }); player.on('fullscreenchange', function() { window.dataLayer.push({ event: "Videos", eventCategory: 'Video', eventAction: "Video Fullscreen Toggled", eventLabel: event_label }); }); player.on('enterpictureinpicture', function() { window.dataLayer.push({ event: "Videos", eventCategory: 'Video', eventAction: "Video Picture-in-Picture Opened", eventLabel: event_label }); }); player.on('leavepictureinpicture', function() { window.dataLayer.push({ event: "Videos", eventCategory: 'Video', eventAction: "Video Picture-in-Picture Closed", eventLabel: event_label }); }); let lastReportedPercentage = 0; player.on('timeupdate', function() { const currentTime = player.currentTime(); const duration = player.duration(); if (duration) { const progressPercentage = Math.floor((currentTime / duration) * 100); if (progressPercentage % 5 === 0 && progressPercentage !== lastReportedPercentage) { lastReportedPercentage = progressPercentage; var audio_insight_data = { event_type: "video_completed", data: { video_id: post_id, video_url: post_url, percentage: progressPercentage, }, ...insight_data, }; insight.track(audio_insight_data); } } });
"I mean, stuff happens. It's a business. It's not in …
"I mean, stuff happens. It's a business. It's not in …
Brewers' Garrett Mitchell talks about watching his health to manage diabetes
Why Bexar County's DA candidates are avoiding partisan politics
DA candidates Luz Elena Chapa, Ashley Foster and Jason Wolff say party labels don’t define them. Their plans for the felony backlog and diversion show where they differ.
Extension 4-H offers fish stomach science activity for youth in Ellsworth
ELLSWORTH — University of Maine Cooperative Extension will offer Fish Belly Detectives, a hands-on 4-H science activity for youth ages 5-13, on Friday, Nov. 13, from 3 to 4 p.m.,
Shia LaBeouf waged one-sided feud with Hilary Duff, says “Even Stevens” costar
Duff’s own Disney Channel series, “Lizzie McGuire,” was one of the Disney Channel’s defining hits of the 2000s.
Brewers' Garrett Mitchell talks about watching his health to manage diabetes
Milwaukee Brewers center fielder Garrett Mitchell talks about watching his health to manage his diabetes.
How Nathan Fielder's cringe-comedy career led him to Elizabeth Holmes
Spoiler alert! We're discussing the themes and structure of the Elizabeth Holmes documentary "You Can See Everything" and touching on a surprising aspect of its second half, so turn away if you want to go in completely cold.
Memorial Health dietitian highlights importance of blood sugar management
Zeff encourages people to schedule regular medical appointments and get their blood sugar tested, particularly those with a family history of diabetes.
Scientists invent implant that can transform sugar in the blood to treat type 2 diabetes
An experimental medical device uses a tiny amount of electricity to spark a chemical reaction and remove extra sugar from the bloodstream.
Former NWSL player says league culture pressured athletes to support political messages they opposed
Elizabeth Eddy says NWSL players faced pressure to wear political shirts or risk teammate backlash, describing a culture with no room for dissent.
Heidi Klum, Queen of Halloween, teases this year’s ‘bloody’ costume
Each year, Klum unveils her full costume at her star-studded costume party on Oct. 31 in New York City.
Political ad blitz fills Texas airwaves as Election Day nears
Stock Market Action Plan: A Preelection Week Primer
The stock market faces a heavy week of earnings from the likes of Alphabet and Amazon, along with a Fed meeting and preelection positioning.
Brian Thomas Jr. could be on the move
Jaguars WR Brian Thomas Jr. is believed to be a trade candidate leading up to deadline
Mountain lion found at Moab business tranquilized, relocated by wildlife officials
A mountain lion spotted at a Moab business was successfully tranquilized and will be relocated by wildlife officials.
1 player Eagles must target at 2026 NFL trade deadline
If the Philadelphia Eagles make any more trades before the 2026 trade deadline , it should almost certainly be as sellers, not buyers. Now sure, could Roseman find a bargain on the margins and make a move, like if a team is willing to take a conditional seventh-round pick for a player at a position of need – safety, anyone? -instead of releasing […] The post 1 player Eagles must target at 2026 NFL trade deadline appeared first on ClutchPoints.
Billy Evans suggested the shower scene in 'You Can See Everything'
"You Can See Everything" director Lance Oppenheim said that Elizabeth Holmes' partner, Billy Evans, suggested he be filmed in the shower.
Funding plan to bring Sphere entertainment venue to National Harbor passes Prince George's County Council
Mission Health hospitals collect 289 pounds in 'Crush the Crisis' drug take-back day
One simple step. For some local hospitals - that makes a big difference in keeping dangerous medications out of the wrong hands.
In his own words: Trump on gas prices and energy costs since launching the war with Iran
Since launching the war with Iran nearly eight months ago, U.S. President Donald Trump has struggled to quell soaring energy costs, undermining Republicans’ attempt to keep control of Congress in the midterm elections next week.
Nathan Fielder's Elizabeth Holmes documentary 'You Can See Everything' ended, but the story didn't. Here's what's happened since.
Warning: Don’t read this article if you haven’t seen Fielder's critically acclaimed film, as it contains plenty of spoilers.
Without tight end Cole Kmet, Bears may run more jumbo six-lineman formations
Bloomington business continues to blossom
.video-js, .video-js .vjs-tech { position: relative; width: 100%; height: auto; z-index: 0; } var player = videojs('player_block_5edfa3f5f9d6bd7214107fe1898f7108'); player.nuevo({ contextMenu: false }); var vast = { started: false, paused: false, resumed: false, ended: false, }; var video = { started: false, paused: false, resumed: false, ended: false, } var event_label = 'Video: 210181 - Article: Bloomington business continues to blossom'; var post_id = 210180; var post_url = "https://www.insideindianabusiness.com/videos/bloomington-business-continues-to-blossom"; player.vastAds({ tagURL: "https://servedbyadbutler.com/vast.spark?setID=13487&ID=177008&pid=117129", id: "PreRoll" }); player.on('vast.adStart', function() { vast.started = true; }); player.on('vast.adError', function() { vast = { started: true, ended: true }; }); player.on('play', function() { if (vast.ended && !video.paused) { video.started = true; window.dataLayer.push({ event: "Videos", eventCategory: 'Video', eventAction: "Video Played", eventLabel: event_label }); var audio_insight_data = { event_type: "video_played", data: { video_id: post_id, video_url: post_url }, ...insight_data, }; insight.track(audio_insight_data); } if (video.started && video.paused) { video.resumed = true; window.dataLayer.push({ event: "Videos", eventCategory: 'Video', eventAction: "Video Resumed", eventLabel: event_label }); var audio_insight_data = { event_type: "video_resumed", data: { video_id: post_id, video_url: post_url }, ...insight_data, }; insight.track(audio_insight_data); } }); player.on('pause', function() { if (vast.ended) { video.paused = true; window.dataLayer.push({ event: "Videos", eventCategory: 'Video', eventAction: "Video Paused", eventLabel: event_label }); var audio_insight_data = { event_type: "video_paused", data: { video_id: post_id, video_url: post_url }, ...insight_data, }; insight.track(audio_insight_data); } }); player.on('ended', function() { //vast.adEnd fires after ended, pointless to use. vast.ended = true; if (video.started && !video.ended) { video.ended = true; window.dataLayer.push({ event: "Videos", eventCategory: 'Video', eventAction: "Video Ended", eventLabel: event_label }); } var audio_insight_data = { event_type: "video_completed", data: { video_id: post_id, video_url: post_url, percentage: 100, }, ...insight_data, }; insight.track(audio_insight_data); }); player.on('fullscreenchange', function() { window.dataLayer.push({ event: "Videos", eventCategory: 'Video', eventAction: "Video Fullscreen Toggled", eventLabel: event_label }); }); player.on('enterpictureinpicture', function() { window.dataLayer.push({ event: "Videos", eventCategory: 'Video', eventAction: "Video Picture-in-Picture Opened", eventLabel: event_label }); }); player.on('leavepictureinpicture', function() { window.dataLayer.push({ event: "Videos", eventCategory: 'Video', eventAction: "Video Picture-in-Picture Closed", eventLabel: event_label }); }); let lastReportedPercentage = 0; player.on('timeupdate', function() { const currentTime = player.currentTime(); const duration = player.duration(); if (duration) { const progressPercentage = Math.floor((currentTime / duration) * 100); if (progressPercentage % 5 === 0 && progressPercentage !== lastReportedPercentage) { lastReportedPercentage = progressPercentage; var audio_insight_data = { event_type: "video_completed", data: { video_id: post_id, video_url: post_url, percentage: progressPercentage, }, ...insight_data, }; insight.track(audio_insight_data); } } });
You Can See Everything and the science of spotting liars
It feels like everyone we know is talking about the new documentary You Can See Everything. It tracks the effort of comedian and documentarian Nathan Fielder to suss out how deceptive Elizabeth Holmes, disgraced founder of the company Theranos, is. And after watching the film, we all left the theater wondering -- what could we see? How possible is it to ever really spot someone lying? So we of course called up an expert in deception and counter-deception research, Maria Hartwig, a professor of psychology at CUNY, the City University of New York. For more on sussing out a liar, check out our episode about what's wrong with the polygraph. Interested in more deep dives on the science behind pop culture blockbusters? Email us your question at shortwave@npr.org.Support public media with NPR+ and enjoy perks for over 25 podcasts like this one. This show’s perks include sponsor-free listening. Learn more at plus.npr.org.
Trump campaigns in Mississippi, highlighting Republicans\' challenges
President Donald Trump is campaigning in Mississippi as both parties make their closing arguments ahead of midterm elections in eight days. And the Mississippi Democrat that Trump wants defeated stopped
'You Can See Everything' Surges With $19.5M at Box Office; 'Clayface' Takes No. 1
NEW YORK (AP) — DC Studios scored a modest, R-rated win with “Clayface,” landing a $24 million opening weekend, according to studio estimates Sunday. But the biggest success story in theaters remained A24’s Elizabeth Holmes documentary “You Can See Everything,” which pulled in $19.5 million in its ...
Why did the Patriots release Bryce Baringer? Mike Vrabel explains.
Baringer was released after three seasons as the Patriots’ punter.
"I mean, stuff happens. It's a business. It's not in …
"I mean, stuff happens. It's a business. It's not in …
Trump campaigns Mississippi, highlighting Republicans\' challenges
President Donald Trump is campaigning in Mississippi as both parties make their closing arguments ahead of midterm elections in eight days. And the Mississippi Democrat that Trump wants defeated stopped
Disinformation videos, likely from Russia, are exploiting real people to malign Senate candidates
Social media videos believed to be linked to Russia are misusing real people’s names and photographs to spread disinformation about two Democratic Senate candidates.
Matthew Perry’s sister explains how his addiction struggles inspired her career as a psychotherapist
Matthew Perry’s sister, Mia Perry Bowick, explained how the ‘Friends’ star’s substance use disorder impacted her decision to become a psychotherapist.
It Ain’t Just Sports: Trailblazer and diving coach, Diane Maiese
In this episode: We sit down with Diane Maiese, the first AND only Black woman to win an NCAA Championship and be named a four-time, all-American, in diving.
Michigan basketball gets reality check in exhibition loss vs Houston
Michigan writer Tony Garcia offers three observations from the Wolverines' 83-66 loss to Houston in its final exhibition.
Trump returns to Texas for a high-stakes push to keep the state in Republican hands
President Donald Trump is in Texas to support Republican Ken Paxton's U.S. Senate campaign against Democrat James Talarico.
More voters are leaving party labels behind, as national politics reshape West Virginia
MORGANTOWN – Christine Riley spent most of her life as a Democrat, following a political affiliation that had been part of her family for generations. But after the Jan. 6, 2021, attack on the U.S. Capitol, the 63-year-old retired 911 dispatcher decided she no longer wanted to belong to either major political party. Riley, a […]
Could aliens have visited Earth before humans developed civilization? Some scientific clues keep the question alive
Earth’s deep past leaves plenty of unanswered questions. None currently proves an alien visit, but scientists know the geological record does not preserve everything.
Healthcare costs are on the rise in Minnesota, a top issue for voters. How much more could you pay?
⚾️ Y! Sports AM: Brewers 10, Rays 1
Milwaukee took a commanding 3-0 World Series lead during the 33rd Sports Equinox.
Report: Seahawks Land Quenton Nelson Ahead of Trade Deadline
The Colts are reportedly sending eight-time Pro Bowler Quenton Nelson to Seattle, and the price was small. #NFL